Weibo Corp. ADR buy Traumtanz
Start price
21.01.23
/
50%
€20.30
Target price
21.01.24
€22.00
Performance (%)
8.87%
End price
04.02.23
€22.10
Summary
This prediction ended on 04.02.23 with a price of €22.10. With a performance of 8.87%, the BUY prediction by Traumtanz for Weibo Corp. ADR closed with a slight gain. Traumtanz has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Weibo Corp. ADR | -6.711% | -6.711% | -40.086% |
iShares Core DAX® | 1.665% | 1.692% | 18.093% |
iShares Nasdaq 100 | -0.475% | 1.483% | 27.860% |
iShares Nikkei 225® | 2.620% | 4.475% | 17.651% |
iShares S&P 500 | -0.091% | 1.099% | 24.873% |
According to Traumtanz what are the pros and cons of Weibo Corp. ADR for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Low dividend yield expected
negative Cash Flow expected
Bad rating
Little Investments for future growth
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Below average Management
Bad culture
Little innovation
Few uniques
Dependend from some customers or products
Growths slower than the competition
Sustainability is little important
Higher risks for its business
Below average Marketposition
Significant cyclical dependencies
Little known brand
Business model of the past or high risk
Comments by Traumtanz for this prediction
In the thread Weibo Corp. ADR diskutieren
Buy mit Kursziel 22,0
In the thread Trading Weibo Corp. ADR
Buy beendet
Stopped prediction by Traumtanz for Weibo Corp. ADR
Weibo Corp. ADR
Start price
Target price
Perf. (%)
€22.10
04.02.23
04.02.23
€20.00
04.02.24
04.02.24
-18.78%
04.03.23
04.03.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Weibo Corp. ADR
Start price
Target price
Perf. (%)
€50.60
16.02.21
16.02.21
€55.00
16.02.22
16.02.22
-44.47%
17.02.22
17.02.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group